featured
2023 Top Story in Cardiology: The STOP-CA Trial
Written by
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Neilan TG, Quinaglia T, Onoue T, et al. Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical Trial. JAMA. 2023;330(6):528-536.
- Thavendiranathan P, Houbois C, Marwick TH, et al. Statins to Prevent Early Cardiac Dysfunction in Cancer Patients at Increased Cardiotoxicity Risk Receiving Anthracyclines. Eur Heart J Cardiovasc Pharmacother. 2023;9(6):515-525.
- Hundley WG, D'Agostino R Jr, Crotts T, et al. Statins and Left Ventricular Ejection Fraction Following Doxorubicin Treatment. NEJM Evid. 2022;1(9):10.1056/evidoa2200097.
- D'Amario D, Laborante R, Bianchini E, et al. Statins as Preventive Therapy for Anthracycline Cardiotoxicity: A Meta-Analysis of Randomized Controlled Trials. Int J Cardiol. 2023;391:131219.
- Lyon AR, López-Fernández T, Couch LS, et al. 2022 ESC Guidelines on Cardio-Oncology Developed in Collaboration With the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43(41):4229-4361.
Disclosure statements are available on the authors' profiles: